Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
January 11 2021 - 7:31AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2021
Commission File Number: 001-38283
InflaRx N.V.
(Translation of registrant's name into English)
Winzerlaer Str. 2
07745 Jena, Germany
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFLARX N.V.
On January 11, 2021, InflaRx N.V. (the “Company”) issued a press release titled “InflaRx Provides Update on Vilobelimab (IFX-1) Development.” The press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
In connection with a conference held by J.P. Morgan, on January 11, 2021, the Company updated and presented its corporate presentation (the “Corporate Deck”). The Corporate Deck is attached hereto as Exhibit 99.2 and is incorporated by reference
herein. The Corporate Deck is also available on the Company’s website located at www.inflarx.de, and the presentation will be available both live and in recorded form on the Company’s website, as well.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
INFLARX N.V.
|
|
|
Date: January 11, 2021
|
By:
|
/s/
|
Niels Riedemann
|
|
Name:
|
Niels Riedemann
|
|
Title:
|
Chief Executive Officer
|
EXHIBIT INDEX
|
|
|
|
|
Press release dated January 11, 2021
|
|
|
InflaRx N.V. January 2021 Corporate Presentation
|
InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
InflaRx NV (NASDAQ:IFRX)
Historical Stock Chart
From Sep 2023 to Sep 2024